iShares Nasdaq Biotechnology Index Fund (IBB) – The goal of this exchange-traded fund (ETF) is to provide investment results that correspond generally to the price-and-yield performance of the Nasdaq Biotechnology Index (NBI).
In short, biotech stocks have broken out from a type of triple-top on a broad accumulation.
This breakout represents a 17-month high with an eventual target of $95 to $100.
The stochastic and other internal indicators are overbought, and investors may want to wait to buy IBB on a pullback to $85, but the course is clear, and that is definitely up.
Related Articles:
- 5 Ways to Tell a Stock is Headed Up
- A Health Care Stock That’s Good for You
- The 5 Cheapest Options Strategies
FREE Stock Picks Every Week!
Get the hottest stocks to buy and sell delivered right to your e-mail inbox every week! Start now.
Comments are currently unavailable. Please check back soon.